A monthly video conference series about how you and LLS are advancing blood cancer research in the quest for cures.
With hosts Drs. Lou DeGennaro, Gwen Nichols and Lee Greenberger
Recent Advances and New Opportunities in Blood Cancer Research and Treatment
January 19, 2021, 3PM ET
The past year saw tremendous gains for blood cancer, even during an unprecedented crisis. In this first LLS Research Now panel of 2021, Drs. Louis DeGennaro and Lee Greenberger will be joined by several LLS-funded researchers for a discussion of the most exciting recent advances shared at the recent American Society of Hematologists Annual Meeting, and what we can expect to see in the year ahead.
Alfred Garfall, MD, MS is an Assistant Professor in the Department of Medicine at the Perelman School of Medicine, University of Pennsylvania. He is focused on novel immunotherapies for multiple myeloma, with emphasis on preventing relapse after response to conventional therapies. With new immunotherapies for myeloma on the verge of approval, Dr. Garfall will speak to this remarkable progress and what it means for patients.
John Leonard, MD is the Richard T. Silver Distinguished Professor of Hematology and Medical Oncology, and Senior Associate Dean for Innovation and Initiatives at the Weill Cornell Medical College in New York City. He leads an internationally recognized clinical program for lymphoma patients and has helped to establish standards of care now practiced across the U.S. He will provide insight into recent advances for lymphoma patients and what milestones we can expect to see in the coming year.
Amer Zeidan, MBBS is an Associate Professor, Department of Internal Medicine, Section of Hematology at the Yale School of Medicine. He is an internationally recognized expert in the clinical management of myeloid malignancies, specializing in MDS and acute myeloid leukemia (AML). He serves as principal investigator on several trials, with a focus on immunotherapy. Dr. Zeidan will share recent gains for AML patients and what new advances are expected in the near future.
All three panelists hold grants funded by the Leukemia & Lymphoma Society.
2021 Tentative Topics:
February: no program scheduled this month
March: IMPACT Grant Program
April: Stop MDS and Beat AML
May: An Update on LLS Children's Initiative
June: ASCO Annual Meeting & Clinical Progress
July: Blood Cancer Discoveries Grants
November 2020: Blood Cancer Prevention & Survivorship (video here)
October 2020: LLS's Venture Philanthropy Model for Accelerating Promising Therapies (video here)
September 2020: The Remarkable Promise of Immunotherapy (video here)
August 2020: Research at the Intersection of COVID-19 and Blood Cancer (video here)
July 2020: A Panel Discussion on the Career Development Program (video here)